Evonetix Demonstrates Novel Enzymatic DNA Synthesis Method
Cambridge, UK 01 March 2022– EVONETIX LTD (‘Evonetix’), the
synthetic biology company bringing semiconductor technology to DNA
synthesis, today announced it has achieved enzymatic DNA synthesis
capability with its proprietary, thermally controlled synthesis
chemistry. The culmination of a three-year development programme,
supported by Innovate UK and in collaboration with Durham University,
the results demonstrate that Evonetix’s unique, semiconductor
array-based platform is compatible with both chemical and enzymatic DNA
synthesis, enabling the production of scarless DNA sequences that are
directly compatible with downstream processing.
More info >> |
